Metraipolis › archive › dc_77d5ce01e829

A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction — Europe PMC PMID:41047813

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41047813
DOI
10.1002/anie.202518623
License (as archived)
solo-consultazione
Archived
2026-11-09T13:50:14.507Z
SHA-256 of the archived text
94b08504d7d5455920eec75568d69890bb56e407fb83e556ea160da22af0ee38
Stable URL of this page
https://metraipolis.com/documento/dc_77d5ce01e829

How to cite

A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction — Europe PMC PMID:41047813 — Europe PMC (en), https://europepmc.org/article/MED/41047813 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_77d5ce01e829 (Metraipolis archive dc_77d5ce01e829, sha256 94b08504d7d5455920eec75568d69890bb56e407fb83e556ea160da22af0ee38)
BibTeX
@misc{dc77d5ce01e829,
  title = {A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction — Europe PMC PMID:41047813},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41047813},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_77d5ce01e829; sha256 94b08504d7d5455920eec75568d69890bb56e407fb83e556ea160da22af0ee38},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41047813. Agents can read the archived copy with the MCP tool read_document.